SCHEMBL227153

SCHEMBL227153

Cc1ccc(CC(C)C=O)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.63
TSHR P16473 1/20 0.63
ACACB O00763 1/20 0.40
CYP2A6 P11509 2/20 0.39
IDO1 P14902 1/20 0.39
HPGD P15428 1/20 0.38
TAAR1 Q96RJ0 2/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
CYP1A2 P05177 1/20 0.37
PPARG P37231 1/20 0.36
PPARA Q07869 1/20 0.36
AGXT P21549 1/20 0.35
CHRM2 P08172 1/20 0.35
MAPT P10636 1/20 0.35
NR3C1 P04150 1/20 0.35
PGR P06401 1/20 0.35
NR3C2 P08235 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31412800 1.00 TP53 (0.63) TP53TSHRACACBCYP2A6IDO1
P-Cymene SCHEMBL23296191 0.91 TP53 (0.54) TP53TSHRACACBIDO1MAPT
SCHEMBL16268509 0.85 TP53 (0.49) TP53TSHRACACBIDO1MAPT
SCHEMBL31412811 0.84 TSHR (0.66) TP53TSHRKMT2AMEN1MAPT
SCHEMBL225582 0.84 TSHR (0.66) TP53TSHRKMT2AMEN1MAPT
SCHEMBL5872655 0.83 TSHR (0.63) TP53TSHRACACBCYP2A6HPGD
SCHEMBL13334658 0.82 TP53 (0.42) TP53TSHRACACBCYP2A6IDO1
SCHEMBL17550074 0.81 TSHR (0.61) TP53TSHRTAAR1
SCHEMBL21439149 0.81 TP53 (0.61) TP53TSHRIDO1HPGDTAAR1
SCHEMBL204959 0.81 TP53 (0.61) TP53TSHRIDO1HPGDTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 588 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12600926-B2 Treatment compositions with modified amino acid dimers for delivering a benefit agent THE PROCTER & GAMBLE COMPANY (US) 2026-04-14 US claimed
US-20260000592-A1 TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF PROCTER & GAMBLE (US) 2026-01-01 US claimed
US-12509643-B2 Pro-benefit-agent compounds with carbon/nitrogen bonds THE PROCTER & GAMBLE COMPANY (US) 2025-12-30 US claimed
EP-4655373-A1 BIODEGRADABLE PERFUME COMPOSITION Givaudan SA (CH) 2025-12-03 EP claimed
US-12398341-B2 Apparatus and compositions for improving scent delivery THE PROCTER & GAMBLE COMPANY (US) 2025-08-26 US claimed
EP-4114914-B1 FRAGRANCE PREMIX COMPOSITIONS AND RELATED CONSUMER PRODUCTS PROCTER & GAMBLE (US) 2025-06-25 EP claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
CN-115210352-B Perfume premix compositions and related consumer products 宝洁公司 2025-03-18 CN claimed
WO-2025051371-A1 A FRAGRANCE PASTILLE SYMRISE AG (DE) 2025-03-13 WO claimed
US-12247180-B2 Apparatus and compositions for improving scent delivery THE PROCTER & GAMBLE COMPANY (US) 2025-03-11 US claimed
EP-2408889-A1 DETERGENT, CLEANING AGENT, AFTERTREATMENT AGENT, OR WASHING AID CONTAINING ALDEHYDES AND HAVING AN ANTIBACTERIAL EFFECT Henkel AG & Co. KGaA (DE) 2012-01-25 EP claimed
US-20120003326-A1 DETERGENT, CLEANING AGENT, AFTERTREATMENT AGENT, OR WASHING AID CONTAINING ALDEHYDES AND HAVING AN ANTIBACTERIAL EFFECT HENKEL AG & CO. KGAA (DE) 2012-01-05 US claimed
EP-2272491-A1 New deodorising compositions and deodorant products containing them Robertet S.A. (FR) 2011-01-12 EP claimed
WO-2010146258-A2 NOVEL DEODORISING COMPOSITIONS AND DEODORISING PRODUCTS CONTAINING SAME ROBERTET S.A. (FR) 2010-12-23 WO claimed
WO-2010105949-A1 DETERGENT, CLEANING AGENT, AFTERTREATMENT AGENT, OR WASHING AID CONTAINING ALDEHYDES AND HAVING AN ANTIBACTERIAL EFFECT HENKEL AG & CO. KGAA (DE) 2010-09-23 WO claimed
WO-2009131692-A1 SUBSTRATES FOR DELIVERY OF PHYSIOLOGICALLY ACTIVE AGENTS THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ALABAMA (US) 2009-10-29 WO claimed
US-5931995-A Ink compositions XEROX CORPORATION (US) 1999-08-03 US claimed
US-5919552-A Coated substrates and methods XEROX CORPORATION (US) 1999-07-06 US claimed
US-5897961-A USEFUL FOR INK JET PRINTING AND ELECTROSTATIC PRINTING XEROX CORPORATION (US) 1999-04-27 US claimed
EP-0270841-A2 2-Methyl-3-(para-methyl-phenyl) propionitrile, its preparation and use as a perfuming agent BASF Aktiengesellschaft (DE) 1988-06-15 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509643-B2 Pro-benefit-agent compounds with carbon/nitrogen bonds HGFAC, PROKR1, FABP2 TP53 1914/4885TSHR 4624/4885ACACB 1536/4885
US-20260000592-A1 TREATMENT COMPOSITIONS WITH ESTERAMINES OR SALTS THEREOF ARGLU1, DAO, PNISR TP53 1004/4885TSHR 1360/4885ACACB 1201/4885
US-12600926-B2 Treatment compositions with modified amino acid dimers for delivering a benefit agent F2, C9, S100A8 TP53 1043/4885TSHR 4589/4885ACACB 2753/4885
US-20120003326-A1 DETERGENT, CLEANING AGENT, AFTERTREATMENT AGENT, OR WASHING AID CONTAINING ALDEHYDES AND HAVING AN ANTIBACTERIAL EFFECT CAT, GPX4, WASHC4 TP53 1123/4885TSHR 4529/4885ACACB 1839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.